431 related articles for article (PubMed ID: 29785138)
1. A review of soft-tissue sarcomas: translation of biological advances into treatment measures.
Hoang NT; Acevedo LA; Mann MJ; Tolani B
Cancer Manag Res; 2018; 10():1089-1114. PubMed ID: 29785138
[TBL] [Abstract][Full Text] [Related]
2. Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma.
Tanriverdi O; Yildiz A
J Oncol Pharm Pract; 2022 Apr; 28(3):635-645. PubMed ID: 35043739
[TBL] [Abstract][Full Text] [Related]
3. Esophageal extraskeletal neoplasm Ewing's sarcoma: Case report.
Khalid H; Hussain N; Shamshad R
Int J Surg Case Rep; 2022 Aug; 97():107399. PubMed ID: 35926382
[TBL] [Abstract][Full Text] [Related]
4. Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review.
Fadare O
Adv Anat Pathol; 2011 Jan; 18(1):60-74. PubMed ID: 21169739
[TBL] [Abstract][Full Text] [Related]
5. The value of adjuvant chemotherapy in the management of sarcomas in children.
Donaldson SS
Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
[TBL] [Abstract][Full Text] [Related]
6. Role of chemotherapy in the management of soft tissue sarcomas.
Krikelis D; Judson I
Expert Rev Anticancer Ther; 2010 Feb; 10(2):249-60. PubMed ID: 20132000
[TBL] [Abstract][Full Text] [Related]
7. [Clinical patterns of soft-tissue sarcoma in children].
Méndez R; Arnáiz S; Montero M; Tellado M; País E; Ríos J; Vela D
Cir Pediatr; 2001 Jan; 14(1):14-20. PubMed ID: 11339112
[TBL] [Abstract][Full Text] [Related]
8. Potential application of genomic profiling for the diagnosis and treatment of patients with sarcoma.
Xu L; Xie X; Shi X; Zhang P; Liu A; Wang J; Zhang B
Oncol Lett; 2021 May; 21(5):353. PubMed ID: 33747210
[TBL] [Abstract][Full Text] [Related]
9. [An ultrastructural analysis of malignant soft tissue tumors].
Tsuneyoshi M
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1577-83. PubMed ID: 3592702
[TBL] [Abstract][Full Text] [Related]
10. NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis.
Lai JP; Robbins PF; Raffeld M; Aung PP; Tsokos M; Rosenberg SA; Miettinen MM; Lee CC
Mod Pathol; 2012 Jun; 25(6):854-8. PubMed ID: 22388761
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in the genomics of soft tissue sarcomas.
Conley AP; Trent J; Zhang W
Curr Opin Oncol; 2008 Jul; 20(4):395-9. PubMed ID: 18525334
[TBL] [Abstract][Full Text] [Related]
12. The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.
Ryan CW; Desai J
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714556
[TBL] [Abstract][Full Text] [Related]
13. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
14. Advances in sarcoma genomics and new therapeutic targets.
Taylor BS; Barretina J; Maki RG; Antonescu CR; Singer S; Ladanyi M
Nat Rev Cancer; 2011 Jul; 11(8):541-57. PubMed ID: 21753790
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic dissemination of bone and soft tissue sarcomas: a lymphographic investigation.
Tallroth K
Acta Radiol Suppl; 1976; 349():1-84. PubMed ID: 206099
[TBL] [Abstract][Full Text] [Related]
16. Extremities Soft Tissue Sarcomas, more Common and as Dangerous as Bone Sarcomas.
Voltan K; Baptista AM; Etchebehere M
Rev Bras Ortop (Sao Paulo); 2021 Aug; 56(4):419-424. PubMed ID: 34483383
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
[TBL] [Abstract][Full Text] [Related]
18. Soft tissue sarcomas, a look into the future: different treatments for different subtypes.
Reichardt P
Future Oncol; 2014 Jun; 10(8 Suppl):s19-27. PubMed ID: 25048045
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
[TBL] [Abstract][Full Text] [Related]
20. Making progress in a rare disease: emerging therapeutics in soft tissue sarcomas.
Choe J; Riedel R
F1000Res; 2018; 7():. PubMed ID: 30450193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
